Page last updated: 2024-12-05

n-butyl vinyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

vinilin: RN given refers to cpd with unknown MF; no further information available 10/91 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8108
CHEMBL ID3561125
SCHEMBL ID19482
MeSH IDM0252984

Synonyms (86)

Synonym
AKOS009031191
vinyl butyl ether
n-butyl vinyl ether
ether, butyl vinyl
111-34-2
butoxyethylene
butyl vinyl ether
vinyl n-butyl ether
nsc-8264
wln: 4o1u1
ethenyl n-butyl ether
nsc8264
bve ,
butoxyethene
butane, 1-(ethenyloxy)-
agrisynth bve
ether butylvinylique [french]
hsdb 6384
un2352
ai3-24225
butil vinil eter [spanish]
nsc 8264
brn 1560217
einecs 203-860-7
n-butylvinylether
1-(vinyloxy)butane
inchi=1/c6h12o/c1-3-5-6-7-4-2/h4h,2-3,5-6h2,1h
butyl vinyl ether, contains 0.01% potassium hydroxide as stabilizer, 98%
B0746
vinilin
1-ethenoxybutane
FT-0652515
A802345
shostakovski balsam
vinipol vb 2
vinipol
STL283942
1-(ethenyloxy)butane
unii-321yrt7173
321yrt7173 ,
ec 203-860-7
butyl vinyl ether, inhibited
butyl vinyl ether, inhibited [un2352] [flammable liquid]
4-01-00-02052 (beilstein handbook reference)
ether butylvinylique
butil vinil eter
butyl vinyl ether [hsdb]
1-butoxyethene
n-butyl vinylether
butoxy-ethene
1-vinyloxybutane
1-vinyloxy-butane
n-butylvinyl ether
vinyl-1-butylether
butyl-vinyl ether
butylvinyl ether
vinyl-n-butyl ether
butylvinylether
butyl vinylether
SCHEMBL19482
tox21_303721
dtxsid5051575 ,
cas-111-34-2
NCGC00357033-01
dtxcid9030127
n-c4h9och=ch2
un 2352 (salt/mix)
1-butoxyethylene #
1-(vinyloxy)-butane
shostakovsky balsam (salt/mix)
CHEMBL3561125
J-002562
J-523523
n-butyl vnyl ether
F0001-0239
mfcd00009454
butyl vinyl ether, analytical standard
CS-Z0017
Q1018214
AT27752
butyl vinyl ether (stabilized with trihexylamine)
1-(ethenyloxy)-butane
n-butyl vinyl ether (stabilized with 0.01per cent koh)
25232-87-5
butyl vinyl ether, 98% contains 0.01% potassium hydroxide as stabilizer
EN300-21299

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These results showed that aryl vinyl ethers, NPVE and PVE, are more toxic than the alkyl vinyl ether, BVE, and that glutathione plays an important role on the protection of hepatic injury by reactive metabolite(s) derived from vinyl ethers."( Depletion of glutathione and hepato-toxicity caused by vinyl ethers in mice.
Isobe, M; Sone, T; Takabatake, E, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoid X nuclear receptor alphaHomo sapiens (human)Potency0.27540.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency55.44980.001530.607315,848.9004AID1224841; AID1224848; AID1259403
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's1 (7.14)18.2507
2000's5 (35.71)29.6817
2010's4 (28.57)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.36 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index47.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]